Primary care is key to optimising value in healthcare14 November 2017Balancing improvements in health against the cost of such improvements in primary care is vital to achieve a cost-effective and efficient healthcare system, finds a new report by University of Bristol researchers and published in the BMJ.
NCRI Conference 201710 November 2017This year’s National Cancer Research Institute (NCRI) Conference took place 5 - 8 November 2017 in Liverpool. Amongst the poster presentations was "A randomized controlled feasibility trial of green tea and lycopene interventions in men at elevated risk of prostate cancer (ProDiet)"
NIHR Fellowship18 October 2017Sabina Sanghera was recently awarded a NIHR Post-Doctoral Fellowship.
Centre for Cancer Epidemiology workshop17 October 2017From the 4th to the 14th of October 2017 ten members of the IEU and ICEP embarked on a journey to teach on the Mendelian randomization and Epigenetic Cancer Epidemiology workshop at the Centre for Cancer Epidemiology at the TATA Memorial Centre Advanced Centre for Treatment, Research and Education in Cancer (ACTREC) in Navi Mumbai, India.
New discovery could reverse tissue damage12 September 2017A new discovery by University of Bristol scientists helps to explain how cells which surround blood vessels, called pericytes, stimulate new blood vessels to grow with the hormone ‘leptin’ playing a key role. Leptin is produced by fat cells which helps to regulate energy balance in the body by inhibiting the appetite. This study, described in Scientific Reports, may have important implications for the treatment of heart attacks and also for cancer, the two main killers in the UK.
Big Bang Bristol 31 August 2017Big Bang Bristol is a two day Science, Technology, Engineering and Maths (STEM) fair aimed at school-aged children which this year took place 6 - 7 July 2017 at the Trinity Centre in Bristol.
Bristol researcher wins prestigious diabetes research award24 August 2017A University of Bristol researcher whose own family has been affected by diabetes has just been awarded £587,237 from leading charity Diabetes UK to find out why people with Type 2 diabetes are more likely to develop some cancers.
WUN Strategic Research Workshop1 August 2017The World Universities Network Global Africa Group launched its inaugural Strategic Research Workshop, hosted by the University of Ghana in a two-day event that brought together over sixty researchers from twelve WUN partner universities and ten other universities from four continents.
Phase 3 clinical trial success
27 July 2017A Phase 3 study evaluating Opdivo 3 mg/kg versus Yervoy 10 mg/kg in patients with stage IIIb/c or stage IV melanoma who are at high risk of recurrence following complete surgical resection met its primary endpoint at a planned interim analysis, demonstrating superior recurrence-free survival (RFS) in patients receiving Opdivo compared to Yervoy.
Transforming UK Translation commitments27 July 2017The Academy of Medical Sciences, Royal Academy of Engineering, Royal Society, and the Wellcome Trust, have outlined a series of commitments to ensure that translation is recognised and celebrated as an integral part of academic research.
Clinical Trial recruitment success20 July 2017The UHBristol Haematology and Oncology Centre Clinical Trials Unit are the first to recruit globally for A Study of CYP-001 for the Treatment of Steroid-Resistant Acute Graft Versus Host Disease.
Royal Society report on machine learning
27 June 2017The Royal Society released a report in April 2017 entitled Machine learning: the power and promise of computers that learn by example. Machine learning is a branch of artificial intelligence that allows computer systems to learn directly from examples, data, and experience.
Prehabilitation: boosting patients’ powers of recovery before surgery13 June 2017Improving patients’ health and fitness before a major operation can reduce the risk of complications and help recovery. Yet its potential has not been sufficiently explored. Researchers at Bristol aim to improve surgical outcomes in cancer patients by boosting health in the vital weeks before surgery.
Novel targeting of disease causing cells could transform treatment of autoimmune diseases24 May 2017There is a problem with the traditional treatment of autoimmune and inflammatory conditions. Steroid therapy doesn’t always work, and immunosuppressant drugs can have toxic side effects. Bristol researchers, with the help of an award from the Elizabeth Blackwell Institute, are working to overcome this using novel ways of targeting disease causing cells.
Is there a link between telomere length and cancer?23 March 2017Telomeres are regions of repetitive DNA at the end of human chromosomes, which protect the end of the chromosome from damage. Whilst shorter telomeres are hypothesized biological markers of older age and have been linked to many diseases, including cancer and cardiovascular diseases, whether these associations are causal is unknown.
New EBI Director from 1 August 201717 March 2017following an open, internal, competitive appointment process, Professor Rachael Gooberman-Hill has been appointed to the role of Director of Elizabeth Blackwell Institute, which she will commence on 1 August 2017.
Researchers to develop ‘wearable’ robotic tools for surgery17 March 2017A collaborative team of researchers is to develop a wearable robotic system for minimally invasive surgery, also known as keyhole surgery, that will offer surgeons natural and dexterous movement as well as the ability to ‘sense’, ‘see’, control and safely navigate through the surgical environment.
Early career training and support9 March 2017The Faculties of Biomedical Sciences and Health Sciences have a dynamic postgraduate community enrolled in taught or research-based programmes. Postgrads receive their training in internationally renowned research groups which span the biomedical science disciplines of Biochemistry, Cellular and Molecular Medicine and Physiology, Pharmacology and Neuroscience through to the disciplines associated with population health which include life course epidemiology, genomics, primary care and public health with a particular emphasis on methodology.
£7.5M boost for Health Research8 March 2017The Elizabeth Blackwell Institute (EBI) has been awarded the Wellcome Trust’s Institutional Strategic Support Fund (ISSF), designed to support biomedical research and related activities in the UK over the next five years. The ISSF award of £3.75M is being matched by the University. It is the third and largest ISSF award for the EBI and recognises the successful work the Institute has delivered during the previous five years.
Helping the body’s own defences fight cancer cells23 January 2017Immunotherapy offers the big hope of teaching the body’s immune system to destroy cancer cells, but there’s a major obstacle: cancer cells can stop immune cells from recognising them as a threat.
Engineering the future of cancer treatment 26 October 2016Of the many new developments in cancer research, one of the most promising comes from nanoscience. Bioengineers are designing nanoparticles that can deliver treatments and diagnostics directly to tumours, raising the prospect of much more precise and effective interventions.